| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1979 | 1994 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2004 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
group | 0.380 | None | 0.800 | 5 | 0 | 1999 | 2015 | ||||||||
|
timeless circadian regulator | 0.533 | 0.808 | 9.8E-35 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
interleukin 9 receptor | 0.659 | 0.654 | 2.7E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
D-amino acid oxidase | 0.636 | 0.615 | 6.2E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
vacuolar protein sorting 13 homolog A | 0.650 | 0.577 | 9.3E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
phosphofructokinase, liver type | 0.722 | 0.269 | 2.7E-17 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2006 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha6 | 0.678 | 0.423 | 1.3E-12 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
adenylate cyclase 3 | 0.678 | 0.615 | 2.0E-11 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
group | 0.400 | None | 0.800 | 5 | 0 | 2006 | 2019 | ||||||||
|
phospholipase A2 group IB | 0.468 | 0.846 | 1.0E-10 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 1996 | 2003 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2010 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 1998 | 2014 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1982 | 2009 | ||||||||
|
BSCL2 lipid droplet biogenesis associated, seipin | 0.545 | 0.692 | 1.1E-09 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
group | 0.520 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1993 | 2007 | ||||||||
|
neurotensin receptor 1 | 0.563 | 0.692 | 1.9E-08 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2012 | ||||||||
|
sirtuin 2 | 0.510 | 0.769 | 2.3E-08 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2013 | 2019 |